You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Type 2 Inflammation
AAAAI 2023 | Defining Type 2 Inflammation
Dr. Theresa Guilbert discusses the key cells and mediators involved in type 2 inflammation and how they contribute to barrier dysfunction across pediatric inflammatory diseases.
MD, MS
Theresa Guilbert
Learning objectives
- Examine interconnectivity between type 2 inflammation, barrier disruption, and clinical consequences of type 2 inflammatory diseases such as atopic dermatitis, asthma, and EoE
- Understand onset and persistence of type 2 inflammation and potential disease trajectories of atopic dermatitis, asthma, and EoE in pediatric patients
Description
Join Theresa Guilbert, MD, MS, as she highlights key cells and mediators of type 2 inflammation, and how they contribute to barrier dysfunction across pediatric inflammatory diseases such as AD, asthma, and EoE.
Tags
MAT-GLB-2300884 v2.0 03/2023
About this expert
Pulmonology
Theresa Guilbert
MD, MS
Professor | University of Cincinnati; Director of the Asthma Center | Cincinnati Children’s Hospital Medical Center, Ohio, United States
See author’s profileRelated resources
